BETHLEHEM, PA--(Marketwired - Aug 5, 2016) - B. Braun Medical Inc., a leader in infusion therapy and pain management, is a sponsor of the Association for the Advancement of Medical Instrumentation (AAMI) Foundation, National Coalition for Infusion Therapy Safety and the National Association of Clinical Nurse Specialists, which will host a series of Patient Safety Seminars.
"Improving patient safety and drug library compliance is a commitment B. Braun shares with AAMI," said Mike Golebiowski, Vice President, Automation & Infusion Systems at B. Braun.
On Monday, August 8 from noon - 1 p.m. (EDT), the seminar, "Raising the Bar on Infusion Safety: Patient Safety Initiatives at Western Maryland Health System and Cameron Memorial Community Hospital will be presented by Christine Ruhl, BSN, MBA, CCRN, Director, Critical Care Services for Western Maryland Health System in Cumberland, MD; Scott Hirschy, RN, BS, IT Applications Manager from Cameron Memorial Community Hospital in Angola, IN; and Andrew Aldred, PharmD, MBA, Director of Pharmacy and Material Management from Cameron Memorial Community Hospital.
This webinar describes the journey to infusion therapy safety taken by both a large hospital system and a small community system. Regardless of size, all hospitals are capable of improving patient safety as it relates to infusion therapy. Both hospitals will discuss how they improved compliance with use of their smart pumps' drug libraries. Visit https://attendee.gotowebinar.com/register/6578724789653528580 to register. For upcoming seminars, visit www.aami.org.
Western Maryland uses B. Braun's Outlook® 400 ES smart pumps, and DoseTrac® real-time view, reporting/analytics and unit-based audits, and achieved 100% drug library compliance to avert medication errors. These results were presented at the American Association of Critical-Care Nurses National Teaching Institute conference in 2013.1
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is part of the B. Braun Group of Companies in the U.S., which is headquartered in Bethlehem, Pa., and includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 56,000 employees in more than 60 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
1Data/study on file.